Huons Global Co., Ltd.

KOSDAQ 084110.KQ

Huons Global Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 391.60 M

Huons Global Co., Ltd. Shareholders' Equity is USD 391.60 M for the year ending December 31, 2023, a 6.76% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Huons Global Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 366.81 M, a -18.52% change year over year.
  • Huons Global Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 450.17 M, a 18.79% change year over year.
  • Huons Global Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 378.98 M, a 16.15% change year over year.
  • Huons Global Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 326.29 M, a 0.76% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
KOSDAQ: 084110.KQ

Huons Global Co., Ltd.

CEO Sooyoung Song
IPO Date Dec. 19, 2006
Location South Korea
Headquarters 253C-902 Pangyo-ro
Employees 122
Sector Healthcare
Industries
Description

Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It also provides medical devices, eye drop products, and bio products. The company was formerly known as Huons Co., Ltd. and changed its name to Huons Global Co., Ltd. in June 2016. Huons Global Co., Ltd. was founded in 1965 and is headquartered in Seongnam, South Korea.

Similar companies

086900.KQ

Medy-Tox Inc.

USD 77.77

-3.69%

096530.KQ

Seegene, Inc.

USD 15.77

-2.26%

069620.KS

Daewoong pharmaceutical Co.,Ltd

USD 89.76

-4.42%

StockViz Staff

February 4, 2025

Any question? Send us an email